Critical Therapeutics Seeks Co-Promotion Partner For Zileuton CR
This article was originally published in The Pink Sheet Daily
Executive Summary
The company will downsize Zyflo sales force ahead of expected approval of twice-daily zileuton for asthma.
You may also be interested in...
Critical Breathes Easier After Finding Promotion Partner For Pending Asthma Therapy
Deal with Merck KGaA subsidiary DEY for zileuton CR adds more than 200 reps and expertise in detailing to respiratory physicians.
Critical Breathes Easier After Finding Promotion Partner For Pending Asthma Therapy
Deal with Merck KGaA subsidiary DEY for zileuton CR adds more than 200 reps and expertise in detailing to respiratory physicians.
Critical Therapeutics Submits Zileuton CR
Critical Therapeutics' controlled-release zileuton could cut the current dosing regimen for Zyflo by half, the firm said July 31